Steve Williamson

Steve Williamson joined Outset as Chief Commercial Officer in November 2020, where he is leading the company’s commercial and service organizations. He has over two decades of medical technology industry experience. Prior to joining Outset, he served as the Worldwide President for the Peripheral Intervention (PI) business unit of BD, joining BD as part of the C.R. Bard acquisition in 2017. In the eight years that Steve ran PI, he drove significant revenue growth along with a robust cadence of innovative product launches, numerous acquisitions and global expansion for the End Stage Renal Disease (ESRD), Peripheral Arterial Disease (PAD), and Oncology businesses. Steve joined Bard from Hologic where he was the Senior Vice President and General Manager of the GYN Surgical Products Business.

Steve earned a Bachelor of Business Administration from the University of Massachusetts, Amherst and an MBA from